Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk - TIMER-): study protocol for a randomized controlled trial.

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Jaén-Moreno MJ
- Feu N
- Redondo-Écija J
- Montiel FJ
- Gómez C
- Del Pozo GI
- Alcalá JÁ
- Gutiérrez-Rojas L
- Chauca GM
- Carrión L
- Osuna MI
- Sánchez MD
- Caro I
- Ayora M
- Valdivia F
- López MS
- Poyato JM
- Sarramea F
Abstract
There is an increased risk of premature death in people with severe mental illness (SMI). Respiratory disorders and cardiovascular disease are leading causes of increased mortality rates in these patients, and tobacco consumption remains the most preventable risk factor involved. Developing new tools to motivate patients towards cessation of smoking is a high priority. Information on the motivational value of giving the lung age and prevention opportunities is unknown in this high-risk population.
Datos de la publicación
- ISSN/ISSNe:
- 1745-6215, 1745-6215
- Tipo:
- Article
- Páginas:
- 47-47
- PubMed:
- 30642365
- Factor de Impacto:
- 0,980 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Trials BIOMED CENTRAL LTD
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Keywords
- Bipolar disorder, Chronic obstructive pulmonary disease, Mobile technology, Schizophrenia, Screening, Tobacco cessation
Proyectos y Estudios Clínicos
INFLAMACIÓN, DISBIOSIS Y TRASLOCACIÓN BACTERIANA EN TRASTORNO BIPOLAR Y ESQUIZOFRENIA: INFLUENCIA DEL ESTILO DE VIDA. ESTUDIO PROBILIFE.
Investigador Principal: VICENT BALANZA MARTINEZ
PI16/01770 . INSTITUTO DE SALUD CARLOS III . 2017
Cita
Jaén MJ,Feu N,Redondo J,Montiel FJ,Gómez C,Del Pozo GI,Alcalá JÁ,Gutiérrez L,BALANZÁ V,Chauca GM,Carrión L,Osuna MI,Sánchez MD,Caro I,Ayora M,Valdivia F,López MS,Poyato JM,Sarramea F. Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk - TIMER-): study protocol for a randomized controlled trial. Trials. 2019. 20. (1):p. 47-47. IF:1,883. (3).